Supplier Type
- Manufacturer
- Trader
- contract manufacturer
- Reagent
- custom synthesis
Supplier Region
- Hyderabad(13)
- Gujarat(19)
- Mumbai(22)
- Tamil Nadu(2)
- Maharashtra(10)
- Andhra Pradesh(2)
- Bangalore(1)
- Uttar Pradesh(5)
- Pune(2)
- Ahmedabad(4)
- Vadodara(5)
- Haryana(3)
- Ujjain(1)
- New Delhi(4)
- Madhya Pradesh(1)
- Delhi(4)
- Telangana(2)
- Karnataka(1)
- Kolkata(1)
Purity
- NLT 95%
- More than 95%
- more than 90%
- Greater than 99%
- 99.95%
- 99.85%
- 99.60%
- 99.55%
- 99.42%
- 99.20%
- 99% Minimum
- 99% HPLC
- >99%
- 99%
- > 99%
- 98.21%
- 98.00%
- >98%
- 98%
- 97-99%
- 97.84%
- 97.5%
- 97.00%
- 97%
- 97 %
- 96.40%
- 96.00 % Min
- 96%
- 95.00%
- 95.00 % Min
- 95%
- >95%
- 93.00%
- 93.0 % Min
- >92%
- 90-95%
- 90%-95%
- 90% - 94%
- >90%
- 90%
- 90 % Min.
- 90 % Above
- 72.96%
- 68.0 % Min
- 65%
Package
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 0Customized pack size availaible
- 25mg
- 50mg
- 100mg
- 250mg
- 500mg
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50Kg
- 100Kg
- 1MT
- 1and gm
- 250250 mg.
-
4-(4-Fluorophenyl)-1-Methyl-
1012886-75-7
-
5-[(2-Chloroethyl)(2-hydroxyethyl)aMino]-1-Methyl-1H-benziMidazole-2-butanoic Acid
109882-27-1
-
ethyl 5-(forMylaMino)-1H-pyrazole-4-carboxylate
31055-19-3
-
10-Oxo-10,11-Dihydro-5H-dibenz[b,f]azepine
21737-58-6
-
CefepiMe interMediate (7-PIME)
103121-85-3
-
MHGQFYHUUMZHET-UHFFFAOYSA-N
1796888-45-3
-
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
111664-35-8
-
2,2'-Binaphthalene-6,6'-dicarboxylic Acid
932033-58-4
-
Pantoprazole EP IMpurity E
2115779-15-0
-
Montelukast EP IMpurity E
1187586-58-8
E82CV222K4C E82CV222K2C EVD4903-E DC EMB9352-E EVF8201-E EVF8216-E, Single Phase
Reagent
Note:Package: 1Piece;INR
(E)-Ferrulic Acid 537-98-4
Trader